enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

   www.aol.com/news/novo-nordisk-discontinue...

   "Novo Nordisk will phase out, then permanently discontinue Levemir in the U.S. on December 31, 2024," the company said in a statement. ... reduced patient access and available alternatives. ...

3. Patients push back against Novo Nordisk move to scrap an ...

   www.aol.com/news/patients-push-back-against-novo...

   Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and doctors in a dozen U.S ...

4. Insulin detemir - Wikipedia

   en.wikipedia.org/wiki/Insulin_detemir

   Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]

5. Insulin (medication) - Wikipedia

   en.wikipedia.org/wiki/Insulin_(medication)

   2006 Novo Nordisk Levemir "detemir" insulin analogue approved for clinical use in the US. 2008 Abott laboratories" FreeStyle Navigator CGM" gets approved. [93] 2013 The US Food and Drug Administration (FDA) requested more cardiac safety tests for Insulin degludec. 2015 Insulin degludec was approved by the FDA in September 2015.

6. Novo Nordisk - Wikipedia

   en.wikipedia.org/wiki/Novo_Nordisk

   The company makes several drugs under various brand names, including Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza. [1] Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. [7]

7. AOL

   search.aol.com

   The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.